116 related articles for article (PubMed ID: 38056696)
1. Memantine and SKF82958 but not an enriched environment modulate naloxone-precipitated morphine abstinence syndrome without affecting hippocampal tPA mRNA levels in rats.
Aslan A; Hatırnaz-Ng Ö; Taşar O; Özbek U; Yamantürk-Çelik P
Pharmacol Biochem Behav; 2024 Jan; 234():173688. PubMed ID: 38056696
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
Aricioglu-Kartal F; Uzbay IT
Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
[TBL] [Abstract][Full Text] [Related]
3. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
[TBL] [Abstract][Full Text] [Related]
4. Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats.
Gomaa A; Hashem T; Mohamed M; Ashry E
J Pharmacol Sci; 2003 May; 92(1):50-5. PubMed ID: 12832855
[TBL] [Abstract][Full Text] [Related]
5. Gamma-vinyl-GABA potentiates the severity of naloxone-precipitated abstinence signs in morphine-dependent rats.
Sayin U; Atasoy S; Uzbay IT; Aricioğlu-Kartal F; Koyuncuoğlu H
Pharmacol Res; 1998 Jul; 38(1):45-51. PubMed ID: 9697154
[TBL] [Abstract][Full Text] [Related]
6. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
Koyuncuoğlu H; Aricioğlu F
Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
[TBL] [Abstract][Full Text] [Related]
8. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
[TBL] [Abstract][Full Text] [Related]
9. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
Lee PH; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Popik P; Danysz W
J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
[TBL] [Abstract][Full Text] [Related]
11. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
12. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
13. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.
Baeyens JM; Esposito E; Ossowska G; Samanin R
Eur J Pharmacol; 1987 May; 137(1):9-13. PubMed ID: 3609136
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
Bhargava HN
Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
[TBL] [Abstract][Full Text] [Related]
15. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
[TBL] [Abstract][Full Text] [Related]
17. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.
Maldonado R; Koob GF
Brain Res; 1993 Mar; 605(1):128-38. PubMed ID: 8467382
[TBL] [Abstract][Full Text] [Related]
18. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.
Taylor JR; Lewis VO; Elsworth JD; Pivirotto P; Roth RH; Redmond DE
Psychopharmacology (Berl); 1991; 103(3):407-14. PubMed ID: 2057541
[TBL] [Abstract][Full Text] [Related]
19. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
